financetom
Business
financetom
/
Business
/
Lucid expects bigger quarterly loss than estimated, plans stock offering
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Lucid expects bigger quarterly loss than estimated, plans stock offering
Oct 17, 2024 2:01 PM

(Reuters) -Electric vehicle maker Lucid Group ( LCID ) said it expects to report a bigger-than-expected loss for the third-quarter and announced a public offering of over 262 million shares, sending its shares down 12% in after-market trading on Wednesday.

Additionally, majority stockholder, Saudi Arabia's Public Investment Fund, said it would purchase 374.7 million shares of the company. The fund expects to maintain an ownership of nearly 59% in company.

Lucid expects to report a loss from operations in the range of $765 million to $790 million for the quarter ended Sept. 30.

That compared with analysts' average estimate of $751.65 million loss, according to data compiled by LSEG.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
CFIUS unable to reach consensus on Nippon Steel's U.S. Steel bid, WaPo reports
CFIUS unable to reach consensus on Nippon Steel's U.S. Steel bid, WaPo reports
Dec 23, 2024
Dec 23 (Reuters) - The Committee on Foreign Investment in the United States (CFIUS) has told the White House it is unable to reach a consensus on national security risks involved in Nippon Steel's ( NISTF ) bid for U.S. Steel, the Washington Post reported on Monday. The high-level government review board delivered its final evaluation of the deal late...
Merck to discontinue drug for bacterial infection
Merck to discontinue drug for bacterial infection
Dec 23, 2024
Dec 23 (Reuters) - Merck ( MRK ) will discontinue its drug for a bacterial infection that can lead to fatal diarrhea, the U.S. Food and Drug Administration's website showed on Monday. The antibody drug, Zinplava, was first approved by the regulator in 2016 to prevent the recurrence of Clostridioides difficile infections (CDI). CDI is generally caused by prolonged use...
BRIEF-Nippon Steel Spokesperson - Decline To Comment On Media Report About Us Government Review Board Deadlocked On U.S. Steel Sale
BRIEF-Nippon Steel Spokesperson - Decline To Comment On Media Report About Us Government Review Board Deadlocked On U.S. Steel Sale
Dec 23, 2024
Dec 24 (Reuters) - Nippon Steel Corp ( NISTF ): * NIPPON STEEL SPOKESPERSON: DECLINE TO COMMENT ON MEDIA REPORT ABOUT US GOVERNMENT REVIEW BOARD DEADLOCKED ON U.S. STEEL SALE Source text: Further company coverage: ...
CFIUS unable to reach consensus on Nippon Steel's U.S. Steel bid, WaPo reports
CFIUS unable to reach consensus on Nippon Steel's U.S. Steel bid, WaPo reports
Dec 23, 2024
Dec 23 (Reuters) - The Committee on Foreign Investment in the United States (CFIUS) has told the White House it is unable to reach a consensus on the national security risks involved in Nippon Steel's ( NISTF ) proposed acquisition of U.S. Steel, the Washington Post reported on Monday. The high-level government review board delivered its final evaluation of the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved